Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 261 - 280 of 490 trials
Title Investigatorsort icon Disease(s)
A Phase II Study of Bendamustine and Dexamethasone in Patients with Relapsed Amyloidosis
[Protocol 12-257]
Landau, Heather
  • Hematology
    • Hematologic Disorders
    • Hematologic Malignancies
A Phase I Study of NEOD001 in Patients with Light Chain Amyloidosis
[Protocol 12-280]
Landau, Heather
  • Hematology
    • Hematologic Disorders
    • Hematologic Malignancies
A Phase III Study of Hormone Therapy with and without Chemotherapy in Patients with HER2-Negative Breast Cancer and 1-3 Positive Lymph Nodes and a Recurrence Score of 25 or Less
[Protocol 12-118]
Lake, Diana
  • Breast Cancer
An Observational Study of Treatment Patterns and Outcomes in Patients with Advanced Basal Cell Carcinoma or Basal Cell Carcinoma Nevus Syndrome
[Protocol 13-221]
Lacouture, Mario
  • Basal Cell Carcinoma
A Phase I Study of Topical Calcitriol (Compound 31543) to Prevent Hair Loss in Women Receiving Paclitaxel for Advanced Breast Cancer
[Protocol 11-205]
Lacouture, Mario
  • Breast Cancer
A Phase III Study of Dapsone Gel versus Moisturizer (Placebo) to Treat Cetuximab-Related Rash
[Protocol 13-012]
Lacouture, Mario
  • Colorectal Cancer
  • Head & Neck Cancer
A Phase II Study of High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission after Non-Myeloablative Therapy in Patients with High-Risk Neuroblastoma
[Protocol 09-159]
Kushner, Brian
  • Neuroblastoma
A Phase II Study of High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of Second or Greater Remission of High-Risk Neuroblastoma
[Protocol 09-160]
Kushner, Brian
  • Neuroblastoma
A Phase II Study of High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Primary Refractory Neuroblastoma in the Bone Marrow
[Protocol 09-161]
Kushner, Brian
  • Neuroblastoma
A Phase I Study of the Hu3F8 Antibody plus GM-CSF in Patients with Relapsed/Refractory Neuroblastoma
Relapsed/Refractory
[Protocol 12-230]
Kushner, Brian
  • Neuroblastoma
A Study Offering Treatment with 3F8 and GM-CSF in Patients with High-Risk Neuroblastoma
Relapsed/Refractory
[Protocol 13-260]
Kushner, Brian
  • Neuroblastoma
A Phase I Trial of a Trivalent Vaccine with Escalating Doses of the Immunological Adjuvant OPT-821 Plus Oral ß-Glucan for High-Risk Neuroblastoma
[Protocol 05-075]
Kushner, Brian
  • Neuroblastoma
Memorial Sloan-Kettering Cancer Center Pancreatic Tumor Registry
[Protocol 02-102]
Kurtz, Robert
  • Hepatobiliary
    • Pancreatic Cancer
  • Hereditary Cancer & Genetics
  • Upper Gastrointestinal
    • Pancreatic Cancer
A Study Assessing the Use of Dual Handset Phones to Improve Communication with Inpatients Who Have Limited English Proficiency
[Protocol 14-042]
Kumar, Chhavi
  • Breast Cancer
  • Leukemia
  • Lymphoma
  • Quality of Life
  • Solid Tumors
  • Upper Gastrointestinal
A Phase II Toxicity Study Using Chemotherapy Followed By Intensity Modulated Radiation Therapy to the Pleura in Patients with Locally Advanced Unresectable Malignant Pleural Mesothelioma
[Protocol 08-053]
Krug, Lee
  • Mesothelioma
A Phase II Study of WT-1 Analog Peptide Vaccine in Patients with Malignant Pleural Mesothelioma
[Protocol 10-134]
Krug, Lee
  • Mesothelioma
A Phase II Study of Tremelimumab versus Placebo for Previously Treated Inoperable Mesothelioma
[Protocol 13-092]
Krug, Lee
  • Mesothelioma
A Phase II Study of Neratinib Alone and with Temsirolimus in Patients with Non-Small Cell Lung Cancer with HER2 Mutations
[Protocol 13-087]
Kris, Mark
  • Lung Cancer, Non-Small Cell
A Phase II Study of Intrathecal I131-3F8 in Patients with GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms
[Protocol 05-122]
Kramer, Kim
  • Brain Tumors, Metastatic
  • Brain Tumors, Primary
    • Brain Metastases
  • Neuroblastoma
  • Pediatric Brain Tumors
    • Brain Cancer
    • CNS Cancer
A Study of Vorinostat (SAHA) plus Isotretinoin and Chemotherapy in Infants and Young Children with Embryonal Tumors of the Central Nervous System
[Protocol 12-191]
Kramer, Kim
  • Pediatric Brain Tumors
    • Brain Cancer